Literature DB >> 23917406

Detection and tentative identification of urinary phase I metabolites of phenylacetylindole cannabimimetics JWH-203 and JWH-251, by GC-MS and LC-MS/MS.

Pierce Kavanagh1, Andrej Grigoryev, Alexandra Melnik, Sergey Savchuk, Anton Simonov, Vladimir Rozhanets.   

Abstract

The synthetic phenylacetylindole cannabimimetics, JWH-203 and JWH-251, have been identified in 'herbal' smoking mixtures following the widespread legislative control of 'first generation' compounds such as JWH-018 and CP47, 497(C8). N-Alkylindole cannabimimetics (including phenylacetylindoles) undergo extensive metabolism and little or none of the parent compounds are found in urine. Utilizing GC-MS and LC-MS/MS, a series of JWH-203 and JWH-251 urinary metabolites have been tentatively identified. These are products of mono- and dihydroxylation, monohydroxylation combined with formation of carbonyl group on the N-pentyl chain, carboxylation of N-pentyl chain and N-dealkylation combined with monohydroxylation. Additionally, trihydroxylated metabolites were detected for JWH-203. No parent compounds were detected. The monohydroxylated metabolites with the hydroxyl group positioned on the N-pentyl chain were the most abundant and were found to be suitable for establishing ingestion of JWH-203 or JWH-250. Maximum urinary concentrations of chain-monohydroxylated metabolites were observed at 2.5-3h (JWH-203) and 6-10h (JWH-251) following ingestion. These metabolites were observed (GC-MS) for to 10 and 8 days (JWH-203 and JWH-251, respectively).
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  GC–MS; JWH-203; JWH-251; LC–MS/MS; Metabolite; Synthetic cannabinoid

Mesh:

Substances:

Year:  2013        PMID: 23917406     DOI: 10.1016/j.jchromb.2013.07.005

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Detection of synthetic cannabinoids using GC-EI-MS, positive GC-CI-MS, and negative GC-CI-MS.

Authors:  Rimako Umebachi; Takeshi Saito; Hiromichi Aoki; Akira Namera; Akihiro Nakamoto; Maho Kawamura; Sadaki Inokuchi
Journal:  Int J Legal Med       Date:  2016-08-20       Impact factor: 2.686

2.  Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.

Authors:  Julie A Marusich; Jenny L Wiley; Timothy W Lefever; Purvi R Patel; Brian F Thomas
Journal:  Neuropharmacology       Date:  2017-11-04       Impact factor: 5.250

3.  Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans.

Authors:  Shimpei Watanabe; Unnikrishnan Kuzhiumparambil; My Ann Nguyen; Jane Cameron; Shanlin Fu
Journal:  AAPS J       Date:  2017-04-28       Impact factor: 4.009

4.  Using cheminformatics to predict cross reactivity of "designer drugs" to their currently available immunoassays.

Authors:  Matthew D Krasowski; Sean Ekins
Journal:  J Cheminform       Date:  2014-05-10       Impact factor: 5.514

5.  One-step extraction and determination of 513 psychoactive substances, drugs, and their metabolites from hair by LC-MS/MS.

Authors:  Jadwiga Musiał; Jolanta Powierska-Czarny; Jakub Czarny; Michał Raczkowski; Natalia Galant; Bogusław Buszewski; Renata Gadzała-Kopciuch
Journal:  Arch Toxicol       Date:  2022-08-25       Impact factor: 6.168

6.  HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study.

Authors:  Tao Yi; Lin Zhu; Guo-Yuan Zhu; Yi-Na Tang; Jun Xu; Jia-Yi Fan; Zhong-Zhen Zhao; Hu-Biao Chen
Journal:  Sci Rep       Date:  2016-09-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.